Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. - Leurs,P.B.; Stolk,R.P.; Hamulyak,K.; Van Oerle,R.; Grobbee,D.E.; Wolffenbuttel,B.H. (Diabetes Care, 2002)